CMAJ • August 14, 2007; 177 (4). doi:10.1503/cmaj.061284.
© 2007 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Résumé
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hughes, C. A.
Right arrow Articles by Miedzinski, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hughes, C. A., PharmD
Right arrow Articles by Miedzinski, L. J., MD
Related Collections
Right arrow Adverse drug reactions
Right arrow Français
Right arrowRelated Articles

Interaction between lopinavir/ritonavir and warfarin

Christine A. Hughes, PharmD, Andrea Freitas, BSc and Lilly J. Miedzinski, MD

From the Faculty of Pharmacy and Pharmaceutical Sciences (Hughes, Freitas), and the Division of Infectious Diseases, Department of Medicine (Miedzinski), University of Alberta; and Capital Health (Hughes), Edmonton, Alta.


View this table:
[in this window]
[in a new window]

  		Table 1.